Shortlisted in July alongside industry peers Almac Group, Kiwi Biosciences, MEDISONAL and Phaim Pharma, TauRx are delighted to have won the Research and Development Achievement Award, recognising our commitment to finding an effective and accessible disease modifying treatment for Alzheimer’s disease.
Marcus Wischik, Special Projects & Alternate Director, attended the event held at the Hilton Hotel, Deansgate, Manchester on Thursday 28 September.
He said: “The team will be delighted when they hear; those in Singapore and Aberdeen, throughout the world and especially our trial sites. I would absolutely recommend anyone in Life Sciences, Bio Tech – the business of healing people – to come and compete and prove themselves to be part of a great world beating industry.”
Read more here: https://pharmaawards.co.uk/
